Protease-activated receptor-1 antagonists
What are Protease-activated receptor-1 antagonists?
Protease-activated receptor-1 (PAR 1) antagonists have an antiplatelet effect by inhibiting thrombin-related platelet aggregation.
Thrombin's cellular effects are mediated by PARs therefore the action of the PAR 1 antagonists alters signalling in platelets and interferes with platelet activation.
PAR 1 antagonists are used to reduce the risk of thrombotic cardiovascular events in patients who have an increased risk of myocardial infarction or peripheral arterial disease.
List of Protease-activated receptor-1 antagonists:
|Drug Name||Reviews||Avg. Ratings|
Generic name: vorapaxar
|0 reviews||Add rating|
|For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.